Abstract
The evolution in axillary management for patients with breast cancer has resulted in multiple dramatic changes over the past several decades. The end result has been an overall deescalation of surgery in the axilla. Landmark trials that have formed the basis for the current treatment guidelines are reviewed herein.
Original language | English |
---|---|
Pages (from-to) | 724-729 |
Number of pages | 6 |
Journal | Annals of Surgical Oncology |
Volume | 27 |
Issue number | 3 |
DOIs | |
State | Published - Mar 1 2020 |